PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

Clinpal is the first end-to-end clinical research platform purpose-built for virtual, hybrid and direct-to-patient studies. Patients log in from anywhere, on any device. Study teams leverage powerful data and analytics across the entire lifespan of the trial. And sites get all functionality all in one system, reducing burden.
Clintec (an IQVIA company), established for 22 years, is an award-winning, full-service global clinical research organisation. Our head quarter office is based in Scotland, UK and we have operations across 50+ countries worldwide.
Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Cmed is Where Technology Meets Expertise. No other CRO is better prepared to support Biotech and Biopharma sponsors deliver the future of clinical trials. Technology-led and with specialty expertise in oncology, cell & gene therapy, rare diseases, data science and analytics, we pioneered the processes for delivering next generation trials.
Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and eye diseases. Coave Therapeutics’ next-generation AAV-Ligand Conjugate (‘ALIGATER’) platform enables targeted delivery and enhanced gene transduction to improve the effectiveness of advanced gene therapies for rare diseases. The company is advancing a pipeline of novel therapies targeting CNS and eye diseases where targeted gene therapy using chemically modified AAVs (coAAVs) has the potential to be most effective. Coave Therapeutics, which is headquartered in Paris (France), is backed by leading international life science and strategic investors Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures, Kurma Partners, Idinvest, GO Capital and Sham Innovation Santé/Turenne.
Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing DNA, Viral Vectors and Microbiota for pre-clinical, clinical and commercial supply. In 2019, Cobra became part of the Cognate BioServices family.
Our mission is to apply our breakthroughs in automation solutions for DNA, RNA, and protein synthesis to enable customers to program and "write" synthetic biology that creates sustainable healthcare and technology solutions for some of humanity’s biggest challenges.
Founded in 2010, Cogentia supports pharmaceutical and healthcare companies in getting their products to market and ensuring patient uptake. Based in Cambridge, we are recognised as one of the UK's leading market access consultancies.
We are a dynamic, results-driven organization focused on providing the broadest range of expertise across the various cell types and technologies used in the commercialization of cell and gene therapy for regenerative medicine, cellular immunotherapy, and advanced cell therapy companies, organizations, and institutions.
Due to the increasing complexity of production and manufacturing within the Life Science industry driven by the amazing advances in research, Cognizant and Zenith Technologies help to manage, optimise and control medical device production.
Cognomie provides ground-breaking online Executive coaching and building Mental Fitness to optimise performance in organisations around the world. We do this by offering instant access to expert coaching, to build skills, insight, belief and fulfilment at every level. Our innovative service is delivered online by highly qualified practitioners via our bespoke digital platform, providing sustainable long-term impact, with data and measurable results for the individual, the company and the business.
Cognomie provides ground-breaking online Executive coaching and building Mental Fitness to optimise performance in organisations around the world.
For 20 years, Cogstate has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and patients around the world. We provide rapid, reliable and highly sensitive computerized cognitive tests and support electronic clinical outcome assessment (eCOA) solutions.
Commercial Eyes is the foremost life sciences commercialisation business in Australia and New Zealand. For nearly 20 years we have supported the needs of more than 650 pharmaceutical, medical device, diagnostic and consumer healthcare companies.
Compass Life Sciences was formed in 2018 by veteran recruitment professionals. We now serve a wide range of key specialisms including R&D, Clinical Research, Commercial Operations, Data & Bioinformatics, Regulatory Affairs and Medical Affairs.
For nearly 30 years, Concentrics Research has been a leader in the conduct of Rx-to-OTC Switch and late-stage (Phase II-IV) research for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. With significant funding from Bindley Capital, Concentrics is committed to growth and innovation. This results in a continuous improvement in service offerings for our clients.
Established in 2005, we are a medium sized pharmaceutical company with a rich heritage of commercialising products in complex markets and in therapeutic areas such as women’s health, urology and endocrinology.
ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.